ATE71140T1 - Lactobacillus-acidophilus-bakterienstaemme und diese enthaltende praeparate. - Google Patents

Lactobacillus-acidophilus-bakterienstaemme und diese enthaltende praeparate.

Info

Publication number
ATE71140T1
ATE71140T1 AT86302836T AT86302836T ATE71140T1 AT E71140 T1 ATE71140 T1 AT E71140T1 AT 86302836 T AT86302836 T AT 86302836T AT 86302836 T AT86302836 T AT 86302836T AT E71140 T1 ATE71140 T1 AT E71140T1
Authority
AT
Austria
Prior art keywords
bacteria
lactobacillus acidophilus
strain
preparations containing
bacteria strains
Prior art date
Application number
AT86302836T
Other languages
English (en)
Inventor
Sherwood L Gorbach
Barry R Goldin
Original Assignee
Sherwood L Gorbach
Barry R Goldin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24909071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE71140(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sherwood L Gorbach, Barry R Goldin filed Critical Sherwood L Gorbach
Application granted granted Critical
Publication of ATE71140T1 publication Critical patent/ATE71140T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT86302836T 1985-04-17 1986-04-16 Lactobacillus-acidophilus-bakterienstaemme und diese enthaltende praeparate. ATE71140T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/724,114 US4839281A (en) 1985-04-17 1985-04-17 Lactobacillus strains and methods of selection
EP86302836A EP0199535B2 (de) 1985-04-17 1986-04-16 Lactobacillus-acidophilus-Bakterienstämme und diese enthaltende Präparate

Publications (1)

Publication Number Publication Date
ATE71140T1 true ATE71140T1 (de) 1992-01-15

Family

ID=24909071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86302836T ATE71140T1 (de) 1985-04-17 1986-04-16 Lactobacillus-acidophilus-bakterienstaemme und diese enthaltende praeparate.

Country Status (9)

Country Link
US (2) US4839281A (de)
EP (1) EP0199535B2 (de)
JP (1) JPH0648979B2 (de)
AT (1) ATE71140T1 (de)
AU (1) AU597882B2 (de)
DE (1) DE3683184D1 (de)
DK (1) DK171369B1 (de)
FI (1) FI90086C (de)
NO (1) NO169241C (de)

Families Citing this family (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US4980164A (en) * 1986-10-02 1990-12-25 Bio Techniques Laboratories, Inc. Strains of lactobacillus for enhancing feed conversion efficiency
CH674150A5 (de) * 1987-10-30 1990-05-15 2 Oi Mo G Med I Im N I Pirogov
DK686187D0 (da) * 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
WO1989011858A1 (en) * 1988-06-09 1989-12-14 Whitecliffe Laboratories Limited Treatment of immunodeficiency
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
WO1991011510A1 (fr) * 1990-01-31 1991-08-08 San-Ei Sucrochemical Co., Ltd. $i(LACTOBACTILLUS ACIDOPHILUS F-133, PREPARATION DE BACTERIES D'ACIDE LACTIQUE PREPAREE A PARTIR DE CELUI-CI, ET SON PROCEDE DE PREPARATION)
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
ES2124060T5 (es) * 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
DK0577903T3 (da) * 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
WO1994018997A1 (en) * 1993-02-24 1994-09-01 Valio Ltd. Method of enhancing immune response to oral vaccines
JP2824821B2 (ja) * 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
US5434765A (en) * 1994-03-10 1995-07-18 Holophane Corporation Luminaire assembly
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
HU220190B (hu) * 1994-05-26 2001-11-28 Bracco S.P.A. Humán eredetű Lactobacillus törzsek, ilyen törzseket tartalmazó gyógyászati készítmények és alkalmazásuk
US6036669A (en) 1995-01-13 2000-03-14 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US6277092B1 (en) 1995-01-13 2001-08-21 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
FI104465B (fi) † 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
IT1276783B1 (it) * 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
FR2740471B1 (fr) * 1995-10-31 1997-12-19 Gervais Danone Co Ferments lactiques, et leur utilisation pour l'obtention de produits hypocholesterolemiants
AT405235B (de) * 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
ES2243965T3 (es) * 1996-07-09 2005-12-01 Societe Des Produits Nestle S.A. Procedimiento de secado mediante pulverizacion.
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
DE69712503T2 (de) * 1996-09-06 2002-08-29 Nestle Sa Belüftetes speiseeis mit milchsäurebakterien enthaltende beschichtung
GB9623068D0 (en) * 1996-11-06 1997-01-08 Cultech Limited Microflora
EP1728855A1 (de) * 1996-11-29 2006-12-06 Bio-K Plus International, Inc. Milchsäureferment das einen speziellen Stamm von Lactobacillus acidophilus enthält und Verwendung davon
ES2283027T3 (es) 1996-11-29 2007-10-16 Bio K + International Inc. Fermento lactico que comprende una cepa particular de lactobacilus acidofilus y utilizacion del mismo.
DE69842112D1 (de) * 1997-02-11 2011-03-10 Entpr Ie Trd As Bioresearch Ie Nd daraus hergestellte antimikrobielle mittel
US6093394A (en) 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
ES2262240T3 (es) 1997-07-05 2006-11-16 Societe Des Produits Nestle S.A. Postre congelado con bacterias lacticas y fibras fermentables.
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US7029702B2 (en) 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
ATE501640T1 (de) 1998-08-12 2011-04-15 Nestle Sa Inkorporation von exogenen milchsäurebakterien in die mikroflora
EP1159951A1 (de) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Verwendung von exogenen Milchsäurebakterien-Stämmen zur Behandlung von durch Actinomyces naeslundii hervorgerufene Krankheiten
FR2785809B1 (fr) 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
IT1312098B1 (it) * 1999-04-23 2002-04-04 Proge Farm Srl Metodo di selezione di ceppi di lattobacilli adesivi con proprieta'terapeutiche e ceppi ottenuti con tale metodo.
US6706287B2 (en) 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
US20040197352A1 (en) * 1999-04-30 2004-10-07 Natarajan Ranganathan Methods of improving or augmenting kidney function
US7998470B2 (en) * 1999-04-30 2011-08-16 Kibow Biotech, Inc. Compositions and methods improving renal function
RU2146454C1 (ru) * 1999-05-18 2000-03-20 Анисимова Таисия Ивановна Штамм бактерий lactobacillus acidophilus n.v.ep 317/402 "наринэ" ааа, используемый при приготовлении препаратов, диетических и лечебно-профилактических продуктов для лечения дисбактериоза и его последствий
IL130303A0 (en) 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
US6251432B1 (en) 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
DE19963104A1 (de) * 1999-12-24 2001-06-28 Ralf Kirkamm Mittel zur Behandlung von Bakterienmangel
JP2003535903A (ja) * 2000-06-19 2003-12-02 ミューコプロテック・プロプライエタリー・リミテッド プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
IT1320772B1 (it) * 2000-11-02 2003-12-10 Proge Farm Srl Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
US7214370B2 (en) * 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
BR0116349A (pt) 2000-12-18 2003-12-23 Probiohealth Llc Compostos probióticos derivados da cepa ke01 de lactobacillus casei
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
RU2316586C2 (ru) * 2002-03-21 2008-02-10 Бифодан А/С ПРОБИОТИЧЕСКИЕ ШТАММЫ Lactobacillus (ВАРИАНТЫ) И ИХ ПРИМЕНЕНИЕ
US7300787B2 (en) * 2002-07-05 2007-11-27 Archer-Daniels-Midland Company Lactobacillus strains and use thereof in fermentation for L-lactic acid production
JP4618970B2 (ja) * 2002-08-02 2011-01-26 マルホ株式会社 肛門圧低下外用剤
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
FI113057B (fi) * 2002-11-04 2004-02-27 Valio Oy Menetelmä hiivojen kasvun estämiseksi
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
PL3184275T3 (pl) * 2003-05-22 2020-11-16 Canco Hungary Investment Ltd. Wyroby polimerowe
EP1675617B1 (de) 2003-09-30 2017-07-26 Kibow Biotech, Inc. Zusammensetzungen zur verstärkung der nierenfunktion
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
WO2006073430A2 (en) * 2004-04-20 2006-07-13 The University Of Chicago Therapeutic delivery system comprising a high molecular weight peg-like compound
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
ATE473636T1 (de) * 2005-02-15 2010-07-15 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
CA2604338A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
CN102225078B (zh) 2005-07-26 2012-12-26 内斯特克有限公司 抗肥胖剂及抗肥胖食品
EP3067057B1 (de) 2005-09-28 2022-11-09 Nordic Rebalance A/S Probiotische fermentierte zerealienzusammensetzung zur verwendung bei der behandlung von gastrointestinalen, durch proinflammatorische bakterien verursachten störungen
WO2007093619A1 (en) 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
MY149913A (en) 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
EP1993577B1 (de) * 2006-03-10 2014-02-12 N.V. Nutricia Verwendung von unverdaulichen sacchariden als bester start für einen säugling nach der geburt
AU2013201783B2 (en) * 2006-10-02 2015-06-04 International N&H Denmark Aps Probiotics for use in reducing the incidence and duration of illness
US20080095752A1 (en) * 2006-10-20 2008-04-24 Win-Chin Chiang Method for extending the shelf-life of powdered nutritional formulations which contain viable probiotics
US7387427B2 (en) * 2006-10-20 2008-06-17 Bristol-Myers Squibb Company Method for blending heat-sensitive material using a conical screw blender with gas injection
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
EP1974743A1 (de) 2007-03-28 2008-10-01 Nestec S.A. Probiotika zur Verbesserung der Darm-Biozönose
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP1974735A1 (de) 2007-03-28 2008-10-01 Nestec S.A. Verringerung des Durchfallrisikos
EP2072052A1 (de) 2007-12-17 2009-06-24 Nestec S.A. Verhinderung opportunistischer Infektionen bei Personen mit schwachem Immunsystem
PT2244593E (pt) 2008-01-24 2015-08-26 Nestec Sa Cápsula contendo ingredientes nutricionais e método de distribuição de um líquido nutricional a partir da cápsula
FI121912B (fi) * 2008-02-05 2011-06-15 Valio Oy Probioottien uusi käyttö
SG188887A1 (en) 2008-03-14 2013-04-30 Nestec Sa Synbiotic mixture
EP2127661A1 (de) 2008-05-27 2009-12-02 Nestec S.A. Probiotika zur Verbesserung der Darm-Biozönose
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2147678A1 (de) 2008-07-21 2010-01-27 Nestec S.A. Probiotika zur Erhöhung der IgA-Sekretion bei per Kaiserschnitt geborenen Kindern
EP2391641B1 (de) 2009-02-02 2014-12-24 Valio Ltd. Lactobacillus rhamnosus Pili und Pilus Polypeptiden
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB0914878D0 (en) 2009-08-26 2009-09-30 Plant Bioscience Ltd Competetive exclusion compositions and methods
EP2295535A1 (de) 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotisches Material
US20140093614A1 (en) 2009-09-20 2014-04-03 Mead Johnson Nutrition Company Probiotic stabilization
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
FI20096058A0 (fi) 2009-10-13 2009-10-13 Valio Oy Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
US9226521B2 (en) 2009-12-08 2016-01-05 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
US9474298B2 (en) 2011-10-11 2016-10-25 Mead Johnson Nutrition Company Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
US20130251829A1 (en) 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US10588857B2 (en) 2012-03-29 2020-03-17 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
GB201206599D0 (en) 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
US20130344042A1 (en) 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
DK2900805T3 (da) 2012-09-25 2023-02-27 Aquilon Cyl S L Sanidad Animal Probiotiske og præbiotiske sammensætninger
BR112015011933A8 (pt) 2012-11-23 2022-09-20 Seres Therapeutics Inc Composições bacterianas sinérgicas e métodos de produção e uso das mesmas
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP2951283A4 (de) 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Zusammensetzungen und verfahren
CN110917220A (zh) 2013-02-04 2020-03-27 赛里斯治疗公司 治疗组合物及其使用方法
BR112015023124A2 (pt) 2013-03-14 2017-07-18 Therabiome Llc liberação de organismos probióticos e/ou agentes terapêuticos almejada para o trato gastrintestinal
EP2967077A4 (de) 2013-03-15 2016-09-14 Seres Therapeutics Inc Netzwerkbasierte mikrobielle zusammensetzungen und verfahren
US20160206668A1 (en) 2013-08-22 2016-07-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Production of probiotics by in vitro enrichment of beneficial microorganisms from human or animal microbiota
CN116370507A (zh) 2013-11-25 2023-07-04 赛里斯治疗公司 协同细菌组合物以及其制造方法和用途
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
US20150305359A1 (en) 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
CN108430483B (zh) 2015-11-03 2022-05-17 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
WO2017083069A1 (en) 2015-11-09 2017-05-18 Mjn U.S. Holdings Llc Nutritional compositions comprising a casein hydrolysate, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
ES2965306T3 (es) 2016-12-16 2024-04-12 Gervais Danone Sa Composición probiótica que comprende cepas de Lactobacillus rhamnosus y Lactobacillus paracasei
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
DE102017113263A1 (de) 2017-06-16 2018-12-20 Lactopia GmbH Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
JP2020530840A (ja) 2017-08-14 2020-10-29 セレス セラピューティクス インコーポレイテッド 胆汁うっ滞性疾患を治療するための組成物及び方法
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
CN113194971A (zh) 2018-09-10 2021-07-30 拉克托拜欧有限公司 用于减少病原微生物转移的方法
CN113329733A (zh) 2018-12-21 2021-08-31 莱托生物股份有限公司 包含活微生物的局部组合物
CA3123125A1 (en) 2019-01-04 2020-05-22 Lactobio A/S Strains, composition and method of use
AU2020279533A1 (en) 2019-05-20 2021-12-23 Lactobio A/S Composition for treatment, alleviation or prophylaxis of acne
US20220226382A1 (en) 2019-06-05 2022-07-21 Morinaga Milk Industry Co., Ltd. Nutritional Composition
CN114245748A (zh) 2019-06-13 2022-03-25 莱托生物股份有限公司 包含活微生物的凝胶组合物
US20230173066A1 (en) 2019-07-23 2023-06-08 Frieslandcampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634858A (de) 1962-07-19 1900-01-01
LU44002A1 (de) 1962-07-19 1963-09-03
DE1617755A1 (de) * 1966-10-21 1972-02-17 Rehm Eberhard Verfahren zur Herstellung eines durch selektive Zuechtung von Laktobakterien erhaltenen Praeparates
GB1167196A (en) * 1966-12-12 1969-10-15 Yakult Honsha Kk Lactic Acid Bacteria.
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
IT1141095B (it) * 1980-11-27 1986-10-01 Ravizza Spa Processo di risoluzione della sulpiride racema
US4525351A (en) * 1983-01-11 1985-06-25 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection

Also Published As

Publication number Publication date
JPH0648979B2 (ja) 1994-06-29
DK170186A (da) 1986-10-18
FI860194A (fi) 1986-10-18
DK171369B1 (da) 1996-09-30
NO169241B (no) 1992-02-17
DK170186D0 (da) 1986-04-15
NO169241C (no) 1992-05-27
US4839281A (en) 1989-06-13
FI90086B (fi) 1993-09-15
JPS61280433A (ja) 1986-12-11
AU597882B2 (en) 1990-06-14
AU5611286A (en) 1987-10-22
FI860194A0 (fi) 1986-01-16
US5032399A (en) 1991-07-16
EP0199535B1 (de) 1992-01-02
NO861483L (no) 1986-10-20
DE3683184D1 (de) 1992-02-13
FI90086C (fi) 1993-12-27
EP0199535A2 (de) 1986-10-29
EP0199535A3 (en) 1988-08-03
EP0199535B2 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
ATE71140T1 (de) Lactobacillus-acidophilus-bakterienstaemme und diese enthaltende praeparate.
FI931260A (fi) I tjocktarmen koloniserande lactobacillus-stammar
DK0768375T3 (da) Mælkesyrebakterier
JPS57212122A (en) Antitumor agent and its preparation
SU1692021A3 (ru) Способ получения лечебно-профилактического препарата для нормализации микрофлоры кишечника на основе бактерий рода bifidobacterium
AU6480590A (en) Improvements in and relating to supported lactic acid bacteria cultures
UA23320A (uk) Штам бактерій віfіdовастеrіuм lоnguм, який використовується у виробhицтві бактеріальhих препаратів та фермеhтоваhих молочhих продуктів

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties